Respiratory Pathogen Testing (RPT)
Respiratory illnesses are one of the most common reasons for doctors office visits and are considered serious conditions that require preventative treatment. The Center for Disease Control (CDC) estimates that since 2010, respiratory issues resulted in approximately 710,000 cases of hospitalizations and 56,000 deaths annually. It is important to establish that laboratory testing is the first step in treatment administration because it provides physicians with substantial information in order to diagnose the illness earlier and prevent progression or spread of illness. Respiratory Pathogen Testing (RPT) identifies 19 viral and bacterial targets to identify which pathogen is creating an illness. The results allow physicians to provide quicker and better quality patient care.
- Influenza B
- Parainfluenza 1,2 ,3, 4
- Respiratory Syncytial Virus A
- Respiratory Syncytial Virus B
- Chlamydia Pneumoniae
- Mycoplasma Pneumoniae
- Adenovirus
- Coronavirus (229E, HKU1, NL63, OC43)
- Human Metapneumovirus
- Human Rhinovirus/Enterovirus
- Influenza A
- Influenza A H1
- Influenza A H1-2009
- Influenza A H3